Likewise, serum AFP, CEA, and CA19-9 levels were significantly increased in PLCs relative to healthy controls, indicating that TrxR activity and AFP, CEA, and CA19- are potentially sensitive biomarkers for liver cancer before clinical intervention (Fig. 1B–D). This evidence concerns the gene AFP and liver cancer.